In testing the EP2 antagonist PF-04498148 or the FP antagonist AL8810 against stimuli modeling aspects of systemic diabetes in hMG or hRMEC, respectively, our results underscore the multifaceted disease processes that can drive inflammatory readouts relevant to DR. This evidence concerns the gene PTGER2 and diabetes mellitus.